SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,300,201 | -38.5% | 1,239,251 | -17.6% | 0.00% | -33.3% |
Q2 2023 | $6,991,712 | +169642.9% | 1,503,594 | +68.6% | 0.00% | +50.0% |
Q1 2023 | $4,119 | -62.8% | 891,616 | -34.9% | 0.00% | -66.7% |
Q4 2022 | $11,062 | -99.9% | 1,369,021 | -46.0% | 0.01% | -25.0% |
Q3 2022 | $14,081,000 | +12.1% | 2,537,070 | +5.2% | 0.01% | +14.3% |
Q2 2022 | $12,563,000 | +346.8% | 2,411,392 | +604.8% | 0.01% | +600.0% |
Q1 2022 | $2,812,000 | +29.8% | 342,131 | +134.9% | 0.00% | 0.0% |
Q4 2021 | $2,167,000 | -46.5% | 145,635 | -32.1% | 0.00% | -50.0% |
Q3 2021 | $4,053,000 | -54.4% | 214,583 | -55.1% | 0.00% | -60.0% |
Q2 2021 | $8,888,000 | -32.9% | 478,120 | -17.8% | 0.01% | -44.4% |
Q1 2021 | $13,242,000 | +126.4% | 581,799 | +115.9% | 0.01% | +125.0% |
Q4 2020 | $5,850,000 | +82.4% | 269,484 | -15.6% | 0.00% | 0.0% |
Q3 2020 | $3,208,000 | +124.5% | 319,214 | +73.3% | 0.00% | +100.0% |
Q2 2020 | $1,429,000 | +429.3% | 184,147 | +595.6% | 0.00% | +100.0% |
Q1 2020 | $270,000 | -26.2% | 26,475 | -20.5% | 0.00% | – |
Q4 2019 | $366,000 | +55.1% | 33,303 | +27.9% | 0.00% | – |
Q3 2019 | $236,000 | +11.3% | 26,037 | +39.9% | 0.00% | – |
Q2 2019 | $212,000 | -50.6% | 18,605 | -50.6% | 0.00% | -100.0% |
Q1 2019 | $429,000 | -62.7% | 37,660 | -50.9% | 0.00% | 0.0% |
Q3 2018 | $1,150,000 | – | 76,662 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
BVF INC/IL | 826,825 | $15,371,000 | 0.58% |